Journal article
Emergent use of anticoagulation for treatment of patients with ischemic stroke
Stroke (1970), Vol.33(3), pp.856-861
03/2002
DOI: 10.1161/hs0302.104628
PMID: 11872915
Abstract
Several clinical trials have tested the potential utility of emergent anticoagulation for acute ischemic stroke.
Rather than performing a meta-analysis that combines the data from several trials, this review focuses on individual studies. Although these trials do have inherent limitations, they demonstrate that emergent use of an anticoagulant is associated with a modest but significantly increased risk of hemorrhagic transformation of the ischemic stroke or serious nonneurological bleeding. The trials do not demonstrate a benefit from emergent anticoagulation in improving outcome, reducing mortality, and preventing early recurrent stroke.
These results suggest that most patients with acute stroke should not be treated with unfractionated heparin or other rapidly acting anticoagulants after stroke. Prevention of deep vein thrombosis and pulmonary embolism among bedridden patients is the only established indication for early anticoagulation after acute ischemic stroke.
Details
- Title: Subtitle
- Emergent use of anticoagulation for treatment of patients with ischemic stroke
- Creators
- Harold P Adams Jr - Department of Neurology, University of Iowa College of Medicine, Iowa City 52242, USA. harold-adams@uiuowa.edu
- Resource Type
- Journal article
- Publication Details
- Stroke (1970), Vol.33(3), pp.856-861
- DOI
- 10.1161/hs0302.104628
- PMID
- 11872915
- NLM abbreviation
- Stroke
- ISSN
- 0039-2499
- eISSN
- 1524-4628
- Publisher
- United States
- Language
- English
- Date published
- 03/2002
- Academic Unit
- Neurology; Iowa Neuroscience Institute
- Record Identifier
- 9984020775102771
Metrics
26 Record Views